Recent studies suggest differential roles for CD103+ and CD11b hi lung dendritic cells (LDCs) in host defense against viral and bacterial infections. In this study, we examined the contribution of these LDC subsets in protective immunity to chlamydial lung infection using a Chlamydia muridarum mouse infection model. We found that CD103+ LDCs showed higher expression of costimulatory molecules (CD40, CD80 and CD86) and increased production of cytokines (IL-12p70, IL-10, IL-23 and IL-6) compared with CD11b hi LDCs, but the expression of programmed death-ligand 1 (PD-L1) was similar between the two subsets. More importantly, we found, in adoptive transfer experiments, that the mice receiving CD103+ LDCs from Chlamydia-infected mice exhibited better protection than the recipients of CD11b hi LDCs, which was associated with more robust Th1/Th17 cytokine responses. In addition, in vitro experiments showed that CD103+ LDCs induced stronger IFN-γ and IL-17 responses, when cocutured with chlamydial antigen-primed CD4+ T cells, than CD11b hi LDCs. Furthermore, the blockade of PD1 in the culture of CD4+ T cells with either CD103+ or CD11b hi LDCs enhanced production of IFN-γ and IL-17. In conclusion, our data provide direct evidence that CD103+ LDCs are more potent in promoting Th1/Th17 immunity to chlamydial lung infection than CD11b hi LDCs.
INTRODUCTION
Chlamydia trachomatis, an obligate intracellular bacterium, afflicts people with a broad range of diseases, including sexually transmitted diseases and pneumonia. 1 Recent studies have shown the importance of Th1 immunity particularly IFN-γ production in host defense against Chlamydiae. [2] [3] [4] More recently, it was found that IL-17/Th17 responses are also important for protection against chlamydial lung infection. [5] [6] [7] Significant effort has been made to elucidate the mechanisms underlying differential patterns of cytokine responses in chlamydial infection and to enhance the type of immune responses related to protection.
Lung dendritic cells (LDCs) are professional antigenpresenting cells (APCs), which process and present microbial antigens to initiate T-cell responses to respiratory pathogens. 8 We recently reported that adoptive transfer of LDCs from infected mice can protect the recipient mice from challenge lung infection with chlamydiae. 9 Murine LDCs, which are characterized as CD11c hi MHC-II hi autofluorescence-lung cells, consist of two major subsets, CD11c hi MHC-II hi autofluorescence-CD103+ (CD103+) and CD11c hi MHC-II hi autofluorescenceCD11b hi (CD11b hi ) LDCs. Differences of these two LDC subsets in antigen presentation and immune function have been well documented in reported studies. For example, some studies found CD103+ LDCs are potent at cross-presenting antigens to T cells, whereas CD11b hi LDCs produce large quantities of proinflammatory cytokines. 10, 11 For infections, the role of these LDC subsets has been extensively studied in viral infections, particularly influenza infections with inconsistent results. 12, 13 It was found that although both CD103+ and CD11b hi LDC subsets stimulated CD8+ T cells during influenza infection, CD103+ LDC was the primary subset for cross-presenting viral antigens to CD8+ T cells. 14, 15 In contrast, a study found CD11b hi LDCs to be the predominant subset for CD8+ T-cell responses against influenza. 16 Limited studies have attempted to assess the function of CD103+ and CD11b hi LDCs in response to bacterial pathogens, including intracellular bacteria. [17] [18] [19] Using model antigens and Klebsiella pneumoniae lysate, Hackstein et al. demonstrated that CD103+ and CD11b hi LDCs were potent at priming antigen-specific CD4+ T cells in vitro. 17 Another study showed that during Mycobacterium tuberculosis infection, there was an accumulation of CD103+ LDCs in the lung that produced large quantities of IL-12p40, which played an important role in skewing Th1 responses. 18 Furthermore, CD103+ LDCs isolated from the mice infected with M. tuberculosis induced CD4+ T cells to secrete higher amounts of IFN-γ and IL-17. 19 Interestingly, a recent study in genital tract chlamydial infection found that uterine CD103+ DC subset induced tolerogenic response, while the CD11b+ subset promoted Th1 immunity. 20 However, the role of LDC subsets has yet to be tested in pulmonary chlamydial infection.
Programmed cell death protein 1 (PD1), a surface receptor expressed on activated T and B cells, belongs to the immunoglobulin superfamily. 21 PD1 has two ligands, PD-L1 and PD-L2, which are expressed on APCs, such as macrophages and DCs. 22, 23 PD1/PD-L1 pathway negatively regulates T-cell responses during infections and autoimmunity. [24] [25] [26] [27] Using a genital tract C. trachomatis infection, Fankhauser et al. 24 showed that PD-L1 deficient mice exhibited lower bacterial growth compared with wild-type mice, underscoring the contribution of PD1/PD-L1 pathway to control of infection. PD1 has also been implicated in the negative regulation of DC function during listerial infection. 27 Whether PD1/PD-L interaction modulates the ability of DC subsets, such as CD103+ and CD11b hi DCs, to induce anti-chlamydial immunity needs further exploration.
In this study, we used in vivo and in vitro approaches to examine the role of CD103+ and CD11b hi LDCs in protective immunity to C. muridarum lung infection. We found that both CD103+ and CD11b hi LDC subsets can induce protective immunity but CD103+ subset is more potent in inducing Th1/Th17 responses and protection. In addition, we found that blockade of PD1/PD-L signaling in LDC/T-cell coculture can enhance the capacity of either LDC subsets to promote Th1/Th17 responses, suggesting a negative role of PD1 in regulation of LDC subset-mediated Th1/Th17 immunity to infection. Our results highlight the difference (and commonality) of CD103+ and CD11b hi LDC subsets in protective immunity to a chlamydial lung infection and the universal effect of PD1 blockade on different LDC subsets to induce Th1/Th17 responses in chlamydial infection.
MATERIALS AND METHODS
Organism C. muridarum was cultured and propagated as described previously. 28 Briefly, C. muridarum was grown in HeLa 229 cells in Eagle's MEM (10% FBS and 2 mM L-glutamine) for 48 h. To prepare infection doses, chlamydial elementary bodies (EBs) were purified and stored in sucrose-phosphate-glutamic acid (SPG) buffer at − 80°C, which was used for all experiments under this study. An infection dose of 1 × 10 3 IFUs of C. muridarum in 40 μl of PBS was intranasally inoculated in mice under mild isoflurane anesthesia. The ultraviolet (UV)-killed EBs were used for antigenic stimulation of cells in vitro. For stimulation of mediastinal lymph node (LN) cells, 5 × 10 6 cells were cultured in 1 ml RPMI complete medium that contained UK-EB (1 × 10 4 IFUs/ml). The cell culture was incubated (5% CO 2 ) for 72 h and the supernatants were used for ELISA analysis.
Mice C57BL/6 mice used were males of 6-8 weeks of age. They were bred and maintained at a pathogen-free animal care facility at the University of Manitoba. All experiments were performed in accordance with the guidelines of the Canadian Council of Animal Care and the institutional ethical committee.
Histopathologic analysis
Lung tissues were removed from infected mice and fixed in formalin (10%) and embedded in paraffin for histopathologic analysis. The hematoxylin and eosin (H&E) staining was performed on the tissue sections to analyze the histopathology under light microscope. To quantify the degree of lung inflammation, a semi-quantitative grading system was used as described previously. 6 Flow cytometry Firstly, the lungs were processed to prepare the single-cell suspensions for CD11c-microbead enrichment. CD11c+ lung cells were stained with anti-CD11c-APC, anti-CD11c-PerCPCy5.5, anti-CD11b-APC-Cy7, anti-CD103-PE, anti-MHC-II-APC, anti-MHC-II-PE-Cy7, anti-CD40-PE-Cy5, anti-CD80-PE-Cy5, and anti-CD86-PE-Cy5, anti-PD-L1-PE-Cy7, anti-PD-L1-PECy7 or respective isotype controls. The antibodies were purchased from the eBioscience, San Diego, CA, USA except anti-CD11b-APC-Cy7 antibodies (Biolegend, San Diego, CA, USA). In addition to isotype controls, Fluorescence Minus One (FMO) controls were taken into account. For intracellular cytokine staining in T cells, 5 × 10 6 lung cells were cultured in 1 ml complete RPMI (10% heat-inactivated FBS, 25 μg/ml a gentamicin, 2 mM L-glutamine, and 5 × 10 − 5 2-ME) at 37°C. The cells were then stimulated with 50 ng/ml phorbol 12-myristate 13-acetate (Sigma-Aldrich, St Louis, MO, USA) and 1 μg/ml ionomycin (Sigma-Aldrich) for 3 h. After this incubation, 20 μg/ml brefeldin A (Sigma-Aldrich) was added to accumulate the cytokines inside the cells for 3 more hours. To block the nonspecific binding, the cells were washed and then incubated with FcR blocking Abs (anti-16/32; eBioscience) for 15 min at 4°C. The cells were stained with anti-CD3-FITC, anti-CD4-PE, anti-CD4-PECy7 or respective isotype control Abs (eBioscience), and then fixed and permeabilized with Cytofix/Cytoperm (BD Pharmingen, San Diego, CA, USA) according to the manufacturer's instructions. 
LDC subset isolation
Mice were infected with C. muridarum and their lungs were harvested at day 3 after infection. The lungs were first processed into single-cell suspensions and digested in 10 mg/ ml collagenase XI (Roche Diagnostics, Meylan, France) in RPMI 1640 for 1 h at 37°C. EDTA (5 mM) was also mixed with the suspension. The RBCs were lyzed by ACK lysis buffer (150 mM NH4Cl, 10 mM KHCO 3 , 0.1 mM EDTA). After the lysis, the cell suspension was incubated with CD11c microbeads (Miltenyi Biotec, Auburn, CA, USA) for 15 min at 4°C. The cells were washed and resuspended in cell sorting buffer (Dulbecco's PBS (Sigma-Aldrich) containing 0.5% BSA and 2 mM EDTA). The CD11c+ lung cells were isolated by passing the lung cells through magnetic columns (positive selection).
To purify the LDC subsets, CD11c+ lung cells were sorted using a BD FACSAria II Cell Sorter (BD Biosciences). CD11c hi MHC-II hi autofluorescent-lung cells were gated as LDCs, then displayed into CD103+ and CD11b hi subsets, and sorted. The purity of the sorted LDC subsets was more than 99% as revealed by flow cytometry. LDC subsets were stained with trypan blue and then counted using Hemocytometer.
Adoptive transfer of LDC subsets CD103+ and CD11b hi LDC subsets were isolated from the murine lung at day 3 following infection and then washed in protein-free PBS for intranasal inoculation into naive mice (1 × 10 5 LDCs/mouse). Following the inoculation, the mice Body weights of mice were documented daily. The mice were killed on day 8 after infection challenge and their lungs were excised and processed for estimation of bacterial load as described previously. 28 To test the cytokine levels, the lungs were homogenized in 2 ml PBS, and the supernatants were collected for cytokine analysis by ELISA.
LDC subset-T-cell coculture and PD1-blocking LDC subsets were cultured with splenic CD4+ T cells purified from C. muridarum-immunized mice. For immunization, mice were intraperitoneally inoculated with C. muridarum (1 × 10 3 IFUs) twice at 2 weeks interval. A week after the second immunization, splenic CD4+ T cells were purified from the immunized mice as described previously. 29 (Figure 1a ). Most CD11c hi autofluorescencelung cells did not express F4/80, which is an important marker for pulmonary macrophages (data not shown). We found that both CD103+ and CD11b hi LDC subsets expanded following chlamydial lung infection. The peak of total CD103+ LDCs came very early at day 3 p.i. when their numbers nearly doubled, with a quick decline to lower than baseline level at day 7p.i., whereas the number of CD11b hi LDCs showed steady increase after infection (Figures 1a and b) . Even at day 3 p.i., CD11b hi LDCs were about two times more than the CD103+ LDCs. At day 7 p.i., the difference increased to 15 times due to the decline of CD103+ and the increase of CD11b hi LDCs. These data suggest that both LDCs are responsive to chlamydial infection but CD11b hi subset is the dominant one in terms of expansion/accumulation. To further understand the changes of surface markers related to DC function, we examined the expression of stimulatory and inhibitory molecules on these LDC subsets at day 3 following infection. CD103+ LDCs showed higher expression of CD40, CD80 and CD86 molecules than CD11b hi LDCs (Figures 2a and b) . However, the expression of PD-L1, an immune inhibitory marker, was similar on these LDC subsets. Notably, there was no significant difference in either costimulatory or inhibitory markers between CD103+ and CD11b hi LDCs under steady state conditions (Figures 2a and b) . Overall, chlamydial infection altered both the frequency and phenotype of LDC subsets after infection. (IFN-γ) , whereas IL-23 and IL-6 production skews 
CD103+ LDCs
produced more Th1-and Th17-inducing cytokines than CD11b hi LDCs The cytokine profile of DCs is crucial for polarizing T-cell responses; for example, IL-12 secretion by DCs elicits Th1 responses
Th17 responses (IL-17)
. 30 Therefore, we isolated CD103+ and CD11b hi LDCs from C. muridarum-infected mice with high purity (Figure 3a) , and cultured them for cytokine analysis. Our cytokine analysis showed that both the subsets of LDCs increased IL-12p70, IL-10, IL-23 and IL-6 production but the CD103+ subset secreted higher levels of the cytokines than the CD11b hi LDCs (Figure 3b) . Under uninfected condition, there was no significant difference between CD103+ and CD11b hi for their cytokine production (Figure 3b) . Collectively, chlamydial infection resulted in an enhanced production of Th1-and Th17-inducing cytokines by LDCs, particularly by CD103 + LDCs.
Adoptive transfer of CD103+ LDCs isolated from C. muridarum-infected mice conferred better protection against chlamydial challenge than CD11b hi LDCs To evaluate the relative capacity of LDC subsets in protective immunity, we intranasally transferred CD103+ and CD11b hi LDCs isolated from C. muridarum-infected mice into naive syngeneic mice that subsequently received a challenge with chlamydial infection. A group of mice that received PBS with the same infection challenge were used as controls. We found that the recipients of either LDC subsets showed reduced body weight loss, and bacterial burden in comparison with the recipients of PBS, but the CD103+ LDC recipients were better protected than the recipients of CD11b hi LDCs (Figures 4a and b) . Consistently, the mice receiving CD103+ LDCs exhibited milder lung pathology than CD11b hi LDC recipients (Figures 4c and d) . These findings conclude that both CD103 + and CD11b hi LDC subsets induce protection, but the CD103 + LDCs is more potent in doing so.
Adoptive transfer of CD103+ LDCs induced stronger Th1/Th17 responses following challenge infection To explore the mechanism by which the transferred LDC subsets mediate protection to challenge infections, we analyzed the lung tissues and the LN cells of the recipients of LDCs for their cytokine production. The analysis showed that the recipients of LDC subsets produced higher levels of IFN-γ and IL-17 than PBS recipients (Figures 5a and b) . More significantly, the recipients of CD103+ LDCs exhibited even higher IFN-γ and IL-17 production than the ones receiving CD11b hi LDCs. In contrast, IL-4 production was lower in CD103+ LDC recipients than those receiving CD11b hi LDCs (Figures 5a and b) . To further confirm the differences in T-cell cytokine responses at single-cell level, we analyzed the cytokine (Figures 6a and b) . Thus, these findings suggest that CD103+ LDCs are more potent in inducing Th1 and Th17 responses against chlamydial infection than CD11b hi LDCs.
CD103+ LDCs induced higher IFN-γ and IL-17 secretion by chlamydial antigen-primed CD4+ T cells than CD11b hi
LDCs, and the blockade of PD1 enabled both subsets to promote production of these cytokines To more directly confirm the directive effect of LDCs on T-cell cytokine production, we cocultured antigen-primed CD4+ T cells with the LDC subsets. CD4+ T cells were isolated from C. muridarum-immunized and cocultured with CD103+ or CD11b hi LDC subsets isolated from the mice after infection. The culture supernatants were evaluated for IFN-γ and IL-17. The data showed that the levels of IFN-γ and IL-17 were significantly higher in the culture wells with CD103+ LDCs than CD11b hi LDCs, suggesting stronger capacity of the CD103+ LDCs in promoting Th1/Th17 responses (Figure 7a ). Considering that both LDC subsets express PD-L1, we further investigated the role of PD1/PD-L1 signaling in LDC subset-mediated polarization of T-cell responses. We found that the addition of anti-PD1 antibodies to the coculture of LDC subsets and CD4+ T cells increased IFN-γ and IL-17 secretion by CD4+ T cells in coculture with either LDC subset (Figure 7b ). The level of increase was also comparable between the two types of coculture (around 30%). Notably, when the PD1/PD-L1 signaling was blocked, the capacity of CD11b hi LDCs to promote IFN-γ and IL-17 production was increased to the level of CD103+ LDCs whose PD1 was not blocked (Figure 7b ). These results suggest that reduction of PD1/PD-L1 signaling is an efficient way to enhance LDC function, particularly making the less efficient LDC subset more potent in function. Collectively, these data confirm the stronger ability of CD103+ LDCs in promoting Th1/Th17 responses and suggest the potential of reducing PD1/PD-L1 signaling in improving the function of LDC subsets to induce protective immunity.
DISCUSSION
In this study, we employed in vitro and in vivo systems to assess the role of CD103+ and CD11b hi LDC subsets in promoting Th1 and Th17 response to C. muridarum lung infection. We found that CD103+ LDCs expressed higher levels of costimulatory surface molecules and produced larger quantities of cytokines related to Th1 and Th17 responses compared with CD11b hi LDC. Using adoptive transfer approach, we found that CD103+ LDCs induced better protection against challenge chlamydial lung infection than CD11b hi LDCs, which had stronger bias toward Th1 (IFN-γ) and Th17 (IL-17) responses in the CD103+ LDC recipients than those receiving CD11b hi LDCs. The in vitro experiments of coculturing antigen-primed CD4+ T cells with LDC subsets confirmed the strong capacity of CD103+ LDCs to promote Th1 and Th17 responses. In addition, by adding blocking anti-PD1 monoclonal antibody to the coculture, we showed the enhancing effect of reducing PD1/PD-L1 signaling on the function of the LDC subsets in directing Th1 and Th17 responses. The blockade for PD1 signaling raised the capacity of CD11b hi LDCs to the level of CD103+ LDCs without PD1 blocking. These data provide new insights into the role of LDC subsets in the lung in chlamydial infection and suggest a potential way of enhancing DC function to improve protective immunity in chlamydial infections. In contrast to our findings that both CD103+ and CD11b hi LDC subsets could promote protective Th1/Th17 immunity to chlamydial lung infection, and that CD103+ LDCs were more potent in inducing the immunity, Stary et al. have recently reported that unlike CD103 − CD11b+, CD103+ DCs in the murine uterus preferentially induce tolerance during C. trachomatis genital infection. 20 The reason for the discrepancy between our data and the reported finding remains unclear, but various factors may be involved. In addition to the apparent difference of chlamydial strains used in the studies, the location of infection is likely a more relevant factor. Indeed, many studies have shown difference in the protective mechanism in the genital tract and lung models of chlamydial infections. In particular, although the protective role of IL-17 in chlamydial lung infection models have been repeatedly demonstrated, [5] [6] [7] its role in genital tract infection appears detrimental. 3, 31 Although a tolerogenic role for CD103+ DCs has mostly been reported in intestinal and genital tract models, 20, [32] [33] [34] [35] the role of CD103+ DCs in inducing protective immunity are more commonly found in the lung infection models. For example, a recent study has shown that CD103+ LDCs were able to induce robust Th1/Th17 immunity to M. tuberculosis lung infection. 19 Different function of CD103+ DCs in the lung and genital tract models was also reflected in the phenotype of these cells observed in different studies on chlamydial infections. For example, Stary et al.'s 20 study found increased expression or production of CD80, CD86 and IL-12 only by CD103-CD11b+ DCs but not CD103+ DCs, whereas our data showed more dramatic increase in the expression and production of these molecules on CD103+ DCs. Considering the critical importance of these molecules in inducing and directing T-cell responses, it is not surprising that CD103+ DCs in the two locations are functionally different. Another important point to be noted is the various roles of LDC subsets in controlling IL-17/Th17 immunity against different infections. Schlizer et al. 36 showed that IRF4-dependent CD11b+ LDCs control IL-17 responses in an Aspergillus fumigatus fungal infection. In contrast, during Streptococcus pneumoniae bacterial infection, CD103+ LDCs played a crucial role in regulating IL-17 responses, 37 which is in line with our findings. The results suggest that the type of response generated can be controlled differentially by LDC subsets in response to specific infectious agents.
Studies have shown that CD103+ and lymphoid CD8α+ DCs are functionally and developmentally related because they share the same transcription factor, Batf3 and are efficient in cross-presenting antigens to CD8+ T cells. Despite their differences in phenotype and anatomical location, it appears that CD103+ LDCs and CD8α+ splenic DCs (SDCs) begin to elicit similar immune responses once they sense 'danger signals'. Recent reports further illustrate the expression of a unique chemokine receptor, XCR1, on these DC subsets. 38, 39 Our previous studies, using CD8α+ and CD8α − SDCs, demonstrated that CD8α+ SDCs conferred a stronger Th1 immunity to C. muridarum infection than CD8α − SDCs. 40 In line with these findings, the present study showed that CD103+ LDCs induced similar Th1 protective immunity, as of CD8α+ SDCs, in response to C. muridarum infection. This supports the concept of CD8α+ and CD103+ DCs as a unified and conserved subset of DCs. 39 However, our data have yet to show a direct link between these two types of DCs. Further study is necessary to characterize the relationship between CD8α+ and CD103+ DCs in chlamydial lung infection. Notably, some studies have functionally characterized CD8α+ and CD8α − SDCs as DC-1 and DC-2 like cells, which preferentially induce Th1 and Th2 responses, respectively. 41, 42 However, in case of chlamydial infection, CD8α − , similar to CD8α+, SDCs induced Th1 immunity, 40 which is in contrast to the DC-2 like activities (Th2) shown by CD8α − SDCs. Similar function, as performed by CD8α − SDCs, was observed for CD11b hi LDCs in our present study. In addition to CD103+, CD11b hi LDCs also conferred Th1 immunity to chlamydial infection, indicating that not only CD8α+ SDCs and CD103+ LDCs but also CD8α − SDCs and CD11b hi LDCs show similarity in their immune functions. This is also in line with the finding in mycobacterial infection where both CD8α+ and CD8α − DCs induced protective immunity although the former were more efficient in doing so. 43 It is important to directly analyze the immune responses in different infection models including locations without extrapolating the findings from one infection model to the other. Recent studies have shown that PD1/PD-L1 interaction emits inhibitory signals that suppress DC-mediated immunity against bacterial infections. 19 In this study, we showed that PD1/PD-L1 pathway commonly impeded the function of CD103+ and CD11b hi LDC subsets during chlamydial The interaction between PD1 and PD-L1 negatively affects the functioning of LDC subsets. Interestingly, the level of PD-L1 expression on both LDC subsets was similar, so the difference of the two subsets in function was not because of PD1 expression. However, it was found that the blockade of PD1 enhanced the function of both subsets in inducing Th1/Th17 responses and more importantly that the blockade of PD1 on CD11b hi LDC increased its capacity to induce Th1/Th17 responses to the level of CD103+ LDCs (Figure 7b ). This finding is encouraging because it suggests that manipulating immunosuppressive molecules in DCs may be a way to enhance the efficacy of chlamydial vaccine in inducing protective immunity. These data provide new insights into the role of PD1 receptor signaling in regulating T-cell immunity through influencing DC subsets and the potential to target this molecule on DC subsets in improving vaccination strategy.
In conclusion, our findings from this study demonstrate that CD103+ and CD11b hi LDCs are crucial for protection against chlamydial infection. Both subsets enhance Th1/Th17 immune responses, but the CD103+ LDCs are more potent in doing do than the CD11b hi LDCs. Furthermore, PD1/PD-L pathway negatively regulates the function of LDC subsets to confer T-cell immunity. These findings have implications for developing strategies for control and treatment of respiratory bacterial infections.
